Using riboflavin, UV light in specialized device reduces SARS-CoV-2 pathogens in plasma, whole blood
The research team used existing technologies to treat nine plasma and three whole-blood products.
The research team used existing technologies to treat nine plasma and three whole-blood products.
Over the last decade, there have been advances in manufacturing and in strategies to rapidly produce a vaccine.
Propelled by the COVID-19 pandemic, a CSU research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically modified form of the well-known probiotic Lactobacillus acidophilus, a bacterium commonly ingested in yogurt and other foods for gut health.
CSU leadership, researchers and alumni are working together to produce hand sanitizer for the campus community.
As the world looks for ways to stop the spread of the new coronavirus, Colorado State University has activated a unique combination of national experts, facilities, and vaccine manufacturing capability to help in the fight.
The Zoetis team will explore the livestock immune system and target new immunotherapies.
John Wyckoff talks about a new research project to develop a human vaccine against the Rift Valley Fever virus.
Ray Goodrich has been recognized for his contributions to the U.S. Army Medical Department.
A study conducted at the Infectious Disease Research Center shows that common soil and waterborne microorganisms could play a role in protecting this dangerous pathogen between outbreaks.
BioMARC, the university's vaccine manufacturing facility, created material to be used in labs nationwide in the fight against Zika virus.